OACC — Oaktree Acquisition III Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $261.81m
- $260.54m
Annual cashflow statement for Oaktree Acquisition III Life Sciences, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | 12 M | 12 M |
| Source: | 10-K | 10-K | |
| Standards: | — | USG | USG |
| Status: | fx Preliminary | Final | Final |
| Net Income/Starting Line | — | 1.33 | 7.29 |
| Non-Cash Items | — | -1.64 | -8.48 |
| Other Non-Cash Items | |||
| Changes in Working Capital | — | 0.221 | 0.774 |
| Change in Prepaid Expenses | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | — | -0.09 | -0.422 |
| Other Investing Cash Flow Items | — | -192 | 0.5 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | — | -192 | 0.5 |
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | — | 193 | 0 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | — | 1.36 | 0.078 |